Hetero Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is EFAVIRENZ(FORM-H1), with a corresponding US DMF Number 25028.
Remarkably, this DMF maintains an Active status since its submission on June 09, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 05, 2013, and payment made on December 07, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II